Joshua Hexter insider trades

Open-market stock purchases and sales by Joshua Hexter, COO & CBO at Oramed Pharmaceuticals Inc, from SEC Form 4 filings since Apr 14, 2013.

Recent trades

DateStockTradeValue
Oct 1, 2026ORMP Oramed Pharmaceuticals IncSold$135K
Sep 24, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Sep 24, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Sep 24, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$185K
Sep 24, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$520K
Sep 24, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$500K
Jul 2, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)$185K
Jul 2, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Jul 1, 2026ORMP Oramed Pharmaceuticals IncSold$611K
Mar 17, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Jan 22, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—

Companies traded

  • ORMP Oramed Pharmaceuticals Inc: 2 sales, last Oct 1, 2026

Get free alerts when Joshua Hexter files a new trade →